English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Poster

Is there a Beta-Peptide Equivalent of the Alpha-Helix?

MPS-Authors
/persons/resource/persons21325

Baldauf,  Carsten
Theory, Fritz Haber Institute, Max Planck Society;

/persons/resource/persons22084

Schubert,  Franziska
Theory, Fritz Haber Institute, Max Planck Society;

/persons/resource/persons32738

Pagel,  Kevin
Molecular Physics, Fritz Haber Institute, Max Planck Society;

/persons/resource/persons22220

Warnke,  Stephan
Molecular Physics, Fritz Haber Institute, Max Planck Society;

/persons/resource/persons21421

Rossi,  Mariana
Theory, Fritz Haber Institute, Max Planck Society;

/persons/resource/persons21614

Helden,  Gert von
Molecular Physics, Fritz Haber Institute, Max Planck Society;

/persons/resource/persons21379

Blum,  Volker
Theory, Fritz Haber Institute, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Baldauf, C., Schubert, F., Pagel, K., Warnke, S., Rossi, M., Salwiczek, M., et al. (2014). Is there a Beta-Peptide Equivalent of the Alpha-Helix?. Poster presented at Biophysical Society, 58th Annual Meeting, San Francisco, CA, USA. doi:10.1016/j.bpj.2013.11.3621.


Cite as: https://hdl.handle.net/11858/00-001M-0000-001A-2DDC-B
Abstract
In organic chemistry, the concept of homologation describes the extension of a carbon chain by one methylene unit. The application of this concept to peptides gives rise to the class of β-peptides that feature an additional -CH2- unit in the monomer backbone. The study of such non-natural peptides offers insight into general folding mechanisms. The similarities to α-peptide structure combined with stability against proteases makes such foldamers promising scaffolds with possible applications in drug design.